Anti-NMDAR Encephalitis Clinical Practice Guideline: Improving Time to Diagnosis, Treatment, and Hospital Length of Stay.

Kelsey M Barter D Catherine Fuchs Thomas B Graham Lindsay M Pagano McKenzie Vater

Published in: Neurology. Clinical practice (2023)

Creation of a CPG for patients with suspected AE was associated with an improved time to diagnostic evaluation and treatment. With the CPG, more patients underwent AE testing, though total diagnoses remained the same.

Keyphrases

replacement therapy
end stage renal disease
dna methylation
chronic kidney disease
newly diagnosed
ejection fraction
patient reported
combination therapy
electronic health record
clinical evaluation